Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2009-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1535-7163.MCT-08-0884PMID 19139121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma In vitro and In vivo

  2008cited by this paper
• TAE226‐Induced apoptosis in breast cancer cells with overexpressed Src or EGFR

  2008cited by this paper
• A novel low‐molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth

  2007cited by this paper
• Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma.

  2007cited by this paper
• Sorafenib Inhibits the Imatinib-Resistant KITT670I Gatekeeper Mutation in Gastrointestinal Stromal Tumor

  2007cited by this paper
• Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo

  2007cited by this paper
• Recurrent gastrointestinal stromal tumor (GIST) of the stomach associated with a novel c-kit mutation after imatinib treatment

  2006influential reference
• Up-regulation of focal adhesion kinase in non-small cell lung cancer.

  2006cited by this paper
• Gastrointestinal stromal tumor (GIST).

  2006cited by this paper
• Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

  2006influential reference
• Clinical Significance of Focal Adhesion Kinase in Resectable Pancreatic Cancer

  2006cited by this paper
• Gastrointestinal stromal tumor (GIST)

  2006cited by this paper
• Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants.

  2005cited by this paper
• The role of focal-adhesion kinase in cancer — a new therapeutic opportunity

  2005cited by this paper
• Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.

  2005influential reference
• Multiple connections link FAK to cell motility and invasion.

  2004cited by this paper
• Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs)

  2004cited by this paper
• Role of Expression of Focal Adhesion Kinase in Progression of Hepatocellular Carcinoma

  2004cited by this paper
• Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group.

  2004cited by this paper
• Molecular targets for tumour progression in gastrointestinal stromal tumours

  2004cited by this paper
• Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.

  2004cited by this paper
• Increased Expression of Focal Adhesion Kinase in Thyroid Cancer: Immunohistochemical Study

  2004cited by this paper
• Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

  2003cited by this paper
• The insulin-like growth factor system and cancer.

  2003cited by this paper
• FAK regulates biological processes important for the pathogenesis of cancer

  2003cited by this paper
• Focal adhesion kinase expression is not a prognostic predictor in colon adenocarcinoma patients.

  2003cited by this paper
• Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses.

  2003cited by this paper
• Expression of GRP and its receptor in well-differentiated colon cancer cells correlates with the presence of focal adhesion kinase phosphorylated at tyrosines 397 and 407.

  2003cited by this paper
• Imatinib inhibits various types of activating mutant kit found in gastrointestinal stromal tumors

  2003cited by this paper
• Focal adhesion kinase: the first ten years

  2003cited by this paper
• Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene.

  2002cited by this paper
• Networks and crosstalk: integrin signalling spreads

  2002cited by this paper
• FAK integrates growth-factor and integrin signals to promote cell migration

  2000cited by this paper
• Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes.

  2000cited by this paper
• Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors.

  2000cited by this paper
• Anti-apoptotic Role of Focal Adhesion Kinase (FAK)

  2000cited by this paper
• Focal Adhesion Kinase: a regulator of focal adhesion dynamics and cell movement

  2000cited by this paper
• Anti-apoptotic Role of Focal Adhesion Kinase (FAK): Induction of Inhibitor-of-Apoptosis Proteins and Apoptosis Suppression by the Overexpression of FAK in a Human Leukemic Cell Line, HL-60

  2000cited by this paper
• Signaling through focal adhesion kinase.

  1999cited by this paper
• [Focal adhesion kinase].

  1999cited by this paper
• Focal adhesion kinase and its potential involvement in tumor invasion and metastasis

  1998cited by this paper
• A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors.

  1998cited by this paper
• Focal adhesion kinase expression in oral cancers

  1998cited by this paper
• Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

  1998cited by this paper
• Signal transduction from the extracellular matrix--a role for the focal adhesion protein-tyrosine kinase FAK.

  1996cited by this paper
• The focal adhesion kinase.

  1996cited by this paper
• Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors.

  1995cited by this paper
• pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions.

  1992cited by this paper
• Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin.

  1992cited by this paper

• Claudin-1 Contributes to Gastrointestinal Stromal Tumors (GIST) Resistance to Imatinib Mesylate (IM) via Regulation of FGFR-Signaling

  2025cites this paper
• Fibroblast Growth Factor 2 (FGF2) Activates Vascular Endothelial Growth Factor (VEGF) Signaling in Gastrointestinal Stromal Tumors (GIST): An Autocrine Mechanism Contributing to Imatinib Mesylate (IM) Resistance

  2024cites this paper
• Farnesyltransferase (FTase) Inhibitors Increase Inhibition of KIT Mutants by Imatinib.

  2023cites this paper
• Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary KIT Mutations

  2023cites this paper
• Low-molecular-weight fibroblast growth factor-2 — a viable prognostic factor for gastric gastrointestinal stromal tumors

  2021cites this paper
• Inhibition of FGF2-Mediated Signaling in GIST—Promising Approach for Overcoming Resistance to Imatinib

  2020cites this paper
• Non-Coding RNAs, a Novel Paradigm for the Management of Gastrointestinal Stromal Tumors

  2020cites this paper
• Loss of PI3 kinase association improves the sensitivity of secondary mutation of KIT to Imatinib

  2020cites this paper
• Low-Intensity Pulsed Ultrasound Alleviates Osteoarthritis Condition Through Focal Adhesion Kinase–Mediated Chondrocyte Proliferation and Differentiation

  2020cites this paper
• Ethyl-2-amino-pyrrole-3-carboxylates are active against imatinib-resistant gastrointestinal stromal tumors in vitro and in vivo

  2019cites this paper
• TAE226, a dual inhibitor of focal adhesion kinase and insulin‐like growth factor‐I receptor, is effective for Ewing sarcoma

  2019cites this paper
• Molecular Comparison of Imatinib-Naïve and Resistant Gastrointestinal Stromal Tumors: Differentially Expressed microRNAs and mRNAs

  2019cites this paper
• Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities.

  2019cites this paper
• LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma

  2018cites this paper
• Receptor Tyrosine Kinase-Targeted Cancer Therapy

  2018influential citation
• Inhibition of fibroblast growth factor receptor-signaling sensitizes imatinib-resistant gastrointestinal stromal tumors to low doses of topoisomerase II inhibitors

  2018cites this paper
• Identification of key genes related to high-risk gastrointestinal stromal tumors using bioinformatics analysis

  2018cites this paper
• SOCS1 gene therapy has antitumor effects in imatinib-resistant gastrointestinal stromal tumor cells through FAK/PI3 K signaling

  2018cites this paper
• Attenuation of murine acute lung injury by PF-573,228, an inhibitor of focal adhesion kinase.

  2018cites this paper
• Structure-Based Design, Synthesis, and Characterization of the First Irreversible Inhibitor of Focal Adhesion Kinase.

  2018cites this paper
• miR‐125a‐5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors

  2018cites this paper
• A Novel Receptor Tyrosine Kinase Switch Promotes Gastrointestinal Stromal Tumor Drug Resistance

  2017influential citation
• New targets and therapies for gastrointestinal stromal tumors

  2017influential citation
• Resistance to Tyrosine Kinase Inhibitors in Different Types of Solid Cancer

  2016cites this paper
• The 2016 John J. Abel Award Lecture: Targeting the Mechanical Microenvironment in Cancer

  2016cites this paper
• FAK contributes to proteinuria in hypercholesterolaemic rats and modulates podocyte F‐actin re‐organization via activating p38 in response to ox‐LDL

  2016cites this paper
• Design, synthesis, and evaluation of novel imidazo[1,2-a][1,3,5]triazines and their derivatives as focal adhesion kinase inhibitors with antitumor activity.

  2015cites this paper
• FAK signaling in human cancer as a target for therapeutics.

  2015cites this paper
• MicroRNAs and Gastrointestinal Stromal Tumor.

  2015cites this paper
• Identification of novel Focal Adhesion Kinase binding partners and their biological functions in cancer cells

  2015cites this paper
• MiR-320a downregulation is associated with imatinib resistance in gastrointestinal stromal tumors.

  2014cites this paper
• Design of novel focal adhesion kinase inhibitors using 3D-QSAR and molecular docking

  2014cites this paper
• Integrin VLA-5 and FAK are Good Targets to Improve Treatment Response in the Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

  2014cites this paper
• Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review

  2014cites this paper
• Inhibition of both focal adhesion kinase and fibroblast growth factor receptor 2 pathways induces anti-tumor and anti-angiogenic activities.

  2014cites this paper
• Molecular mechanisms of imatinib resistance in gastrointestinal stromal tumor with focus on microRNAs

  2014cites this paper
• Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST)

  2014cites this paper
• Gastrointestinal stromal tumour: From the clinic to the molecules

  2014cites this paper
• Molecular Markers and Genetic Subtypes

  2013cites this paper
• New findings of kinase switching in gastrointestinal stromal tumor under imatinib using phosphoproteomic analysis

  2013cites this paper
• Structure-based discovery of cellular-active allosteric inhibitors of FAK.

  2013cites this paper
• Gastrointestinal stromal tumors: molecular markers and genetic subtypes.

  2013cites this paper
• FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma

  2012cites this paper
• Oral administration of FAK inhibitor TAE226 inhibits the progression of peritoneal dissemination of colorectal cancer.

  2012cites this paper
• Endothelial FAK as a therapeutic target in disease.

  2012cites this paper
• Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinoma.

  2012cites this paper
• C-KIT mutations were closely associated with the response to Imatinib in Chinese advanced gastrointestinal stromal tumor patients

  2012cites this paper
• Mechanisms of acquired resistance to targeted cancer therapies.

  2012cites this paper
• BIM MEDIATES IMATINIB-INDUCED APOPTOSIS OF GASTROINTESTINAL STROMAL TUMORS: TRANSLATIONAL IMPLICATIONS

  2012cites this paper
• Clinical importance and potential use of small molecule inhibitors of focal adhesion kinase.

  2011cites this paper
• New molecular targets beyond KIT and PDGFRA in gastrointestinal stromal tumors: present and future

  2011influential citation
• Gastrointestinal stromal tumours: origin and molecular oncology

  2011cites this paper
• Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo.

  2011cites this paper
• Down‐regulation of focal adhesion kinase by short hairpin RNA increased apoptosis of rat hepatic stellate cells

  2011cites this paper
• Development of focal adhesion kinase inhibitors in cancer therapy.

  2011cites this paper
• Advances in pathological diagnosis of gastrointestinal stromal tumors

  2010cites this paper
• Evaluation of focal adhesion kinase as a novel radiosensitising target

  2010cites this paper
• Targeting focal adhesion kinase signaling in tumor growth and metastasis

  2010cites this paper
• Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor

  2010cites this paper
• Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer

  2010cites this paper
• Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists.

  2010cites this paper
• Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma

  2010cites this paper
• Hyperphosphorylated FAK Delocalizes from Focal Adhesions to Membrane Ruffles

  2010cites this paper
• Targeting cytoskeleton reorganisation as antimetastatic treatment

  2010cites this paper
• Tyrosine kinases as molecular targets to inhibit cancer progression and metastasis.

  2010cites this paper
• Focal adhesion kinase (FAK) inhibition as a potential strategy for anticancer therapies

  2009cites this paper
• Involvement of focal adhesion kinase in the progression and prognosis of gastrointestinal stromal tumors.

  2009cites this paper
• Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors

  2009cites this paper
• 3D cell cultures of human head and neck squamous cell carcinoma cells are radiosensitized by the focal adhesion kinase inhibitor TAE226.

  2009cites this paper
• Progress in researches about focal adhesion kinase in gastrointestinal tract.

  2009cites this paper
• Green tea (-)-Epigalocatechin-3-gallate inhibits KIT activity and causes caspase-dependent cell death in gastrointestinal stromal tumor including imatinib-resistant cells

  2009cites this paper